Sapna Patel, BA, MD

Sapna Patel, MD of University of Colorado Cancer Center

Sapna Patel, MD, is a professor in the Division of Medical Oncology, the leader of the Cutaneous Oncology Program, and the William Robinson Endowed Chair in Cancer Research at the University of Colorado Cancer Center.

Articles by Sapna Patel, BA, MD

Dr. Patel on the Sequencing of Immunotherapy and Targeted Therapy in BRAF-Mutant Melanoma

BySapna Patel, BA, MD

January 9th 2023

Sapna Patel, BA, MD, discusses the sequencing of immunotherapy and targeted therapy in BRAF-mutant melanoma.

Sapna Patel, MD, medical oncologist, associate professor, director of the Uveal Melanoma Program and Melanoma Fellowship Program, The University of Texas MD Anderson Cancer Center

Dr. Patel on Adjuvant Nivolumab Plus Ipilimumab Regimens in Stage IV Melanoma

BySapna Patel, BA, MD

December 6th 2022

Sapna Patel, MD, discusses the evaluation of adjuvant nivolumab plus ipilimumab in stage IV metastatic melanoma with no evidence of disease.

Dr. Patel on the Neoadjuvant Administration of Pembrolizumab in Advanced Melanoma

BySapna Patel, BA, MD

September 11th 2022

Sapna Patel, BA, MD, discusses the neoadjuvant administration of pembrolizumab in advanced melanoma.

Sapna Patel, BA, MD

Articles by Sapna Patel, BA, MD

Dr. Patel on the Sequencing of Immunotherapy and Targeted Therapy in BRAF-Mutant Melanoma

Dr. Patel on Adjuvant Nivolumab Plus Ipilimumab Regimens in Stage IV Melanoma

Dr. Patel on the Neoadjuvant Administration of Pembrolizumab in Advanced Melanoma

Trending on OncLive

FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer

Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM

FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC

NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer

Dana-Farber Study Finds Dual Immunotherapy May Help Certain Patients With Advanced NSCLC Live Longer